Luis Solera has assumed the position of CEO of Bioiberica. In his career to date, Luis Solera has held various management positions in the Netherlands, Portugal and Spain.
Most recently, he was General Manager of a leading family business in the oils and fats sector.
Kurt Stoffel, President of Bioiberica said: “As CEO of Bioiberica, Luis Solera will play a decisive role in shaping the future of Bioiberica and boosting the success of our company, aided by our experienced team.”
Bioiberica is a biotechnology company specialising in the identification and extraction of biomolecules of high biological and therapeutic value from tissues of animal origin.
It is the leading Western producer of heparin (the world's most commonly used anticoagulant and antithrombotic) and leader in osteoarthritis and joint health for people and animals.
Bioiberica is also specialist in the development and production of high-quality ingredients for farm animal feed and natural products to beat plant stress.
